Vimgreen Pharmaceuticals, a science─driven pharmaceutical company focused on the modulation of adenosine signalling, announced the completion of...

Indian Council of Medical Research (ICMR) and Panacea Biotec declared the start of Phase III clinical trial for India's first dengue vaccine.

Positive Phase 2a Fibromyalgia Results Deliver Pain Reduction in 100% of Patients, Strengthening IP Position and Clinical Trial Strategy Tryptamine...

Pharmadrug Inc (CSE: PHRX) has received approval for its majority owned joint venture, Sairiyo Therapeutics, to process with a Phase 1 clinical study...

BRISBANE, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing...

India's first phase-three trial for an indigenous tetravalent dengue vaccine, DengiALL, was initiated by Panacea Biotec. Conducted across 19 sites,...

Chinese prosecutors have charged a Japanese citizen with espionage, China's Foreign Ministry said Thursday, adding that the rights of those involved...

HANGZHOU, China, Aug. 15, 2024. Vimgreen Pharmaceuticals, a science-driven pharmaceutical company focused on the modulation of adenosine signaling,...

Astria Therapeutics chooses Ypsomed’s YpsoMate as the injection device for STAR-0215 for the treatment of hereditary angioedema Astra Therapeutics...

Tryptamine Therapeutics' (ASX:TYP) Jason Carroll joins Sarah Hughan on Stockhead TV to talk about its drug trial to treat fibromyalgia. ...